rs748368348

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_177438.3(DICER1):​c.4206+9_4206+19delGTGTGTGTGTG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0907 in 1,580,912 control chromosomes in the GnomAD database, including 3,100 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.092 ( 976 hom., cov: 0)
Exomes 𝑓: 0.090 ( 2124 hom. )

Consequence

DICER1
NM_177438.3 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.918

Publications

1 publications found
Variant links:
Genes affected
DICER1 (HGNC:17098): (dicer 1, ribonuclease III) This gene encodes a protein possessing an RNA helicase motif containing a DEXH box in its amino terminus and an RNA motif in the carboxy terminus. The encoded protein functions as a ribonuclease and is required by the RNA interference and small temporal RNA (stRNA) pathways to produce the active small RNA component that represses gene expression. This protein also acts as a strong antiviral agent with activity against RNA viruses, including the Zika and SARS-CoV-2 viruses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2021]
DICER1 Gene-Disease associations (from GenCC):
  • DICER1-related tumor predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • pleuropulmonary blastoma
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • DICER1 syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 14-95099760-ACACACACACAC-A is Benign according to our data. Variant chr14-95099760-ACACACACACAC-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 477187.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.355 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DICER1NM_177438.3 linkc.4206+9_4206+19delGTGTGTGTGTG intron_variant Intron 22 of 26 ENST00000343455.8 NP_803187.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DICER1ENST00000343455.8 linkc.4206+9_4206+19delGTGTGTGTGTG intron_variant Intron 22 of 26 1 NM_177438.3 ENSP00000343745.3

Frequencies

GnomAD3 genomes
AF:
0.0922
AC:
13768
AN:
149290
Hom.:
974
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0364
Gnomad AMI
AF:
0.0241
Gnomad AMR
AF:
0.144
Gnomad ASJ
AF:
0.105
Gnomad EAS
AF:
0.368
Gnomad SAS
AF:
0.139
Gnomad FIN
AF:
0.104
Gnomad MID
AF:
0.0769
Gnomad NFE
AF:
0.0875
Gnomad OTH
AF:
0.0902
GnomAD2 exomes
AF:
0.0598
AC:
13933
AN:
233034
AF XY:
0.0594
show subpopulations
Gnomad AFR exome
AF:
0.0215
Gnomad AMR exome
AF:
0.0679
Gnomad ASJ exome
AF:
0.0461
Gnomad EAS exome
AF:
0.177
Gnomad FIN exome
AF:
0.0553
Gnomad NFE exome
AF:
0.0434
Gnomad OTH exome
AF:
0.0494
GnomAD4 exome
AF:
0.0905
AC:
129542
AN:
1431512
Hom.:
2124
AF XY:
0.0913
AC XY:
65000
AN XY:
711920
show subpopulations
African (AFR)
AF:
0.0305
AC:
963
AN:
31622
American (AMR)
AF:
0.129
AC:
5587
AN:
43358
Ashkenazi Jewish (ASJ)
AF:
0.0871
AC:
2234
AN:
25650
East Asian (EAS)
AF:
0.330
AC:
12676
AN:
38384
South Asian (SAS)
AF:
0.125
AC:
10445
AN:
83820
European-Finnish (FIN)
AF:
0.0890
AC:
4376
AN:
49170
Middle Eastern (MID)
AF:
0.0920
AC:
519
AN:
5644
European-Non Finnish (NFE)
AF:
0.0797
AC:
87192
AN:
1094676
Other (OTH)
AF:
0.0938
AC:
5550
AN:
59188
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.428
Heterozygous variant carriers
0
4835
9670
14505
19340
24175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3630
7260
10890
14520
18150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0922
AC:
13770
AN:
149400
Hom.:
976
Cov.:
0
AF XY:
0.0985
AC XY:
7183
AN XY:
72954
show subpopulations
African (AFR)
AF:
0.0363
AC:
1430
AN:
39420
American (AMR)
AF:
0.144
AC:
2178
AN:
15110
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
364
AN:
3454
East Asian (EAS)
AF:
0.369
AC:
1890
AN:
5122
South Asian (SAS)
AF:
0.139
AC:
664
AN:
4778
European-Finnish (FIN)
AF:
0.104
AC:
1082
AN:
10430
Middle Eastern (MID)
AF:
0.0793
AC:
23
AN:
290
European-Non Finnish (NFE)
AF:
0.0875
AC:
5931
AN:
67800
Other (OTH)
AF:
0.0893
AC:
186
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
548
1097
1645
2194
2742
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.108
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Aug 15, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

DICER1-related tumor predisposition Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Sep 28, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.92
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs748368348; hg19: chr14-95566097; COSMIC: COSV58616789; COSMIC: COSV58616789; API